About Us

VSCP is a private equity firm with substantial and differentiated healthcare services sector and sourcing expertise. Specifically, we specialize in middle market buyouts, with a focus on businesses with strong cash flow characteristics that create value for hospitals, physicians, and health insurers by enhancing efficiency, expanding productivity, reducing costs, and growing revenues. Since inception, the firm has deployed nearly $400 million in capital, primarily as a control investor.

Credit: HLM

History

Founded in 2014, the firm's partners trace a professional history together that goes back over 22 years. The team worked side by side for a long period of time at Lehman Brothers before transitioning to lead M&A and strategy at two of the country's largest healthcare service companies. Throughout that time, they have built C-Suite relationships with many of Corporate America's most successful healthcare organizations. The fund made its initial investment in ScribeAmerica within 60 days of formation.

Expertise

With over 50 combined years of analyzing and investing in healthcare services companies, and with an experienced and prestigious healthcare services-centered advisory board, VSCP possesses unparalleled industry knowledge and expertise. Collectively the team has worked with hundreds of healthcare companies and developed lasting relationships with industry executives and luminaries, which serve as the foundation for our deal-sourcing strategy.

Investment Philosophy

The U.S. Healthcare system is currently experiencing unprecedented change, triggered both by legislated system reform and by key constituent initiatives to drive new models of care. Our experience highlights that these macro changes tend to create significant opportunities to create future value. Fundamentally, we favor middle market companies that provide services to hospitals, physician groups, and payors that reduce costs, enhance efficiency, drive quality and build scale.

Investment Criteria

We invest in U.S. middle-market buyouts in the healthcare services sector

We prefer founder-led and corporate carve-out businesses

Targeted EBITDA of $5-30 million, with the ability to scale significantly higher

We focus on investments that meet our overall firm strategy, rather than check size